SecBot SecBot
8-K ·Filed Jun 18, 2026

PVCT

PROVECTUS BIOPHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001493152-26-029280
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor the annual meeting presentation for any material updates on clinical pipeline or corporate developments. The filing itself is routine and non-directional.

DirectionNeutral
Confidencemedium
Horizonimmediate
Final — all horizons settled through T+60d
PVCT ▼ -8.06% at T+60d
NEUTRAL call -8.06% · α vs SPY -9.96% · entry $0.0620 → $0.0570
Entry = T+0 close
Jun 18, 2026
via day close
T+1d
+6.13%
call +6.13% · α +6.44%
$0.0658
settled 4mo ago
T+5d
+8.06%
call +8.06% · α +10.44%
$0.0670
settled 4mo ago
T+20d
-0.32%
call -0.32% · α +0.14%
$0.0618
settled 3mo ago
T+60d
-8.06%
call -8.06% · α -9.96%
$0.0570
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Provectus Biopharmaceuticals filed an 8-K furnishing its 2026 Annual Meeting of Stockholders presentation slides under Regulation FD. The presentation covers clinical development, regulatory affairs, drug discovery, manufacturing, IP, and business development updates. No financial data or forward guidance was disclosed.

Key Facts

  • Filed 8-K on June 18, 2026, for the annual meeting held the same day.
  • Presentation slides (Exhibit 99.1) cover clinical, regulatory, R&D, manufacturing, IP, and business development.
  • No financial results, guidance, or preliminary metrics were provided in the filing.

Financial Impact

No financial data disclosed; impact cannot be quantified.

Risk Factors

  • Presentation content may contain forward-looking statements that are inherently uncertain.
  • Lack of financial disclosure limits immediate trading signal.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-029280
Document: 0001493152-26-029280-index-headers.html0001493152-26-029280
Document: 0001493152-26-029280-index.html0001493152-26-029280
Document: 0001493152-26-029280.txt0001493152-26-029280
3 reports for PVCT
Performance horizon
Filters
Rows
Reports for PVCT — sortable, filterable
TypeNow
Jun 18, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$0.0620 $0.0618▼ −0.32%▲ +0.14%$0.0490 (−20.97%)
Apr 30, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$0.0570 $0.0650▲ +14.04%▲ +9.07%$0.0490 (−14.04%)
Apr 20, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$0.0530 $0.0680▲ +28.30%▲ +23.39%$0.0490 (−7.55%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 7h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026